JonasVan den Bossche

Partner

Brussels + 32.2.645.14.12

Connect:

Share

Jonas Van den Bossche has more than 16 years of experience in complex domestic and cross-border M&A deals, joint ventures, private equity, and real estate transactions. He also advises clients on general civil, commercial, corporate governance, corporate law, and restructuring issues. Jonas has been with Jones Day since 2008 and also spent 18 months in the Firm's London Office.

Recent representative transactions include Euroclear's acquisition of Spanish-based Banco Inversis from Banca March, Bekaert's acquisition of Bexco from Exmar, Biobest's €500 million acquisition of Biotrop, and Pandox's acquisition of the NH Louise hotel.

Other major companies Jonas has advised include Arsenal Capital, Astellas, Barco, Bridgestone, Diebold, Global City Holdings, Hansteen, Heidrick & Struggles, Hexagon, International Automotive Components Group, MasterCard, Mitsui Chemicals, Nitto, Pioneer, Procter & Gamble, Solvay, Suez, Toyota Motor Corporation, Wabtec Corporation, and Van Hool.

Experience

  • Sanofi to separate its consumer healthcare business, OpellaJones Day is acting as securities law counsel to Sanofi in the separation of Opella, its consumer healthcare business, and the announced sale of a 50% controlling stake.
  • Euroclear acquires Banco InversisJones Day is advising Euroclear SA/NV in its acquisition of Banco Inversis, a leading provider of global investment technology solutions and outsourced financial services.
  • Bekaert acquires BEXCOJones Day advised NV BEKAERT SA in the €40 million acquisition of BEXCO nv, a leading global player in synthetic ropes for offshore energy production, both conventional and renewable.
  • SmartSD enters into strategic partnership with CobepaJones Day advised SmartSD and its longstanding stakeholders Smile Invest, co-founders and management on a strategic partnership with new majority shareholder Cobepa, a leading European private equity company.
  • GfK sells European Consumer Panel (GfK CP) business to YouGovJones Day advised GfK SE in the €315 million sale of its European Consumer Panel business (GfK CP) to YouGov PLC, a leading international online research data and analytics technology group headquartered in the United Kingdom and listed on the London Stock Exchange (LSE: YOU).
  • Biobest acquires BiotropJones Day represented Biobest Group NV, a Belgian developer of biological crop-protection products in its €500 million capital and debt raise for the acquisition of Biotrop Participacoes SA, a provider of biological and natural farming solutions in Brazil, for an enterprise value of about €532 million.
  • Norwest Equity Partners acquires United Sports BrandsJones Day represented Norwest Equity Partners in the acquisition and financing of United Sports Brands, a global leader in sports performance and protective products, including the Shock Doctor, McDavid, Cutters, Nathan, PEARL iZUMi, and Glukos brands.
  • Cortec Group sells Chauvet & Sons to Court Square Capital PartnersJones Day advised Cortec Group in the sale of its Chauvet & Sons platform to Court Square Capital Partners.
  • Diebold Nixdorf obtains $1.25 billion senior secured exit credit facilityJones Day represented Diebold Nixdorf, Incorporated, a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, in connection with a new $1.25 billion senior secured term loan facility as part of it’s emergence from chapter 11 bankruptcy and other domestic and foreign court-supervised restructuring proceedings.
  • Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.
  • Diebold Nixdorf obtains $1.25 billion senior secured superpriority DIP credit facilityJones Day is representing Diebold Nixdorf, Incorporated (the “Company”), a multinational financial and retail technology company that specializes in the sale, manufacture, installation, and service of self-service transaction systems (such as ATMs and currency processing systems), point-of-sale terminals, physical security products, and software and related services for global financial, retail, and commercial markets, and certain of its domestic and foreign subsidiaries (collectively, the “Debtors”) in (i) a pre-packaged chapter 11 proceeding in front of the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”), (ii) a scheme of arrangement by Diebold Nixdorf Dutch Holding B.V. (the “Dutch Issuer”) and the related voluntary proceeding in front of the District Court of Amsterdam under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord), and (iii) an anticipated proceeding commenced by the Dutch Issuer under chapter 15 in the Bankruptcy Court, seeking recognition of such scheme of arrangement.
  • Biobest receives capital increase from Sofina and some private investorsJones Day advised Biobest Group NV in its capital increase in an amount of €98.5 million with cancellation of preferential subscription rights, subscribed by Sofina SA and by other private investors.
  • Sumitomo Bakelite Europe subsidiary acquires industrial land in Ghent, BelgiumJones Day advised Sumitomo Bakelite Europe NV in the acquisition by subsidiary Vyncolit NV of industrial land at the Vynckier site (Ghent, Belgium) from Gegrond BV.
  • Pandox acquires NH Brussels LouiseJones Day advised Pandox AB in the €35 million acquisition of NH Brussels Louise, a hotel in central Brussels, Belgium.
  • iSTAR Medical enters into strategic alliance with AbbVieJones Day advised iSTAR Medical SA in its strategic alliance with AbbVie (NYSE: ABBV).
  • Consortium BelGaN Group BV acquires ON Semiconductor Belgium BVJones Day advised the consortium BelGaN Group BV with the acquisition of ON Semiconductor Belgium BV, a subsidiary of Semiconductor Components Industries, LLC, which designs and manufactures semiconductors components.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • Aurelius sells remaining Office Depot Europe business to strategic buyer RAJA GroupJones Day advised AURELIUS Equity Opportunities in the sale of Office Depot Europe, which includes the remaining Viking and Office Depot Europe activities to strategic buyer RAJA Group.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • EMERAM Capital Partners sells portfolio company MEONA to Trill ImpactJones Day represented EMERAM Capital Partners GmbH, one of the leading investment companies for medium-sized companies in the German-speaking region, in the sale of its portfolio company MEONA, an innovation leader for clinical software, to the private equity firm, Trill Impact.
    • View All

    August 2024 Commentary

    Directors Beware: How to Navigate Belgium's Latest Tort Liability Changes

    December 2020 Commentary

    European Government Support Schemes: Current State of Play

    June 2020 White Paper

    Financial Government Support Measures Related to COVID-19 for European Corporates

    March 2019 Commentary

    Belgium Enacts Historic Corporate Law Reform

    Additional Publications

    • December 2020
      Shareholders’ Agreements following the introduction of the New Belgian Companies and Associations Code (DAOR 2020/4)

    Additional Speaking Engagements

    • June 14, 2022
      Lecture for the Flemish Pleading Association (Vlaams Pleitgenootschap) of the Brussels bar on "An Overview of the Impact of the New Company Code on Existing and New Shareholders' Agreements"
    • January 15, 2019
      ELSA Maastricht lecture on "Introduction to Mergers & Acquisitions in Practice - A Perspective of Law and Business"

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.